Kristina Callis Duffin University of Utah School of Medicine Biography Publications Institution JoVE Articles Kristina Callis Duffin has not added a biography. If you are Kristina Callis Duffin and would like to personalize this page please email our Author Liaison for assistance. Publications PAPRIKA: A Question Bank for Assessing Psoriatic Arthritis Risk in Individuals of Diverse Ancestries Arthritis Care & Research. Mar, 2024 | Pubmed ID: 37691268 Advances and Controversies in Our Understanding of Guttate and Plaque Psoriasis The Journal of Rheumatology. Nov, 2023 | Pubmed ID: 37657796 Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations The Journal of Rheumatology. Jan, 2023 | Pubmed ID: 36319014 Promoting Diversity, Equity, and Inclusion for Psoriatic Diseases The Journal of Rheumatology. Jun, 2022 | Pubmed ID: 35293335 Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry Dermatology (Basel, Switzerland). 2021 | Pubmed ID: 31962340 A Multi-item Physician Global Assessment Scale to Assess Psoriasis Disease Severity: Validation Based on Four Phase III Tofacitinib Studies BMC Dermatology. Jun, 2019 | Pubmed ID: 31174539 The Physician Global Assessment and Body Surface Area Composite Tool is a Simple Alternative to the Psoriasis Area and Severity Index for Assessment of Psoriasis: Post Hoc Analysis from PRISTINE and PRESTA Psoriasis (Auckland, N.Z.). 2018 | Pubmed ID: 30324088 Ustekinumab-induced Remission of Recalcitrant Guttate Psoriasis: A Case Series JAAD Case Reports. Sep, 2017 | Pubmed ID: 28932788 From the Medical Board of the National Psoriasis Foundation: Treatment Targets for Plaque Psoriasis Journal of the American Academy of Dermatology. Feb, 2017 | Pubmed ID: 27908543 Usability of a Novel Disposable Autoinjector Device for Ixekizumab: Results from a Qualitative Study and an Open-label Clinical Trial, Including Patient-reported Experience Medical Devices (Auckland, N.Z.). 2016 | Pubmed ID: 27785115 Desired Improvement Tool (DIT): A Tool to Assess Desire for Improvement in Psoriasis Patients The Journal of Dermatological Treatment. 2016 | Pubmed ID: 26247843 Validity of the Simple-Measure for Assessing Psoriasis Activity (S-MAPA) for Objectively Evaluating Disease Severity in Patients with Plaque Psoriasis Journal of the American Academy of Dermatology. Nov, 2015 | Pubmed ID: 26475541 A Phase 2 Trial of Guselkumab Versus Adalimumab for Plaque Psoriasis The New England Journal of Medicine. Jul, 2015 | Pubmed ID: 26154787 Comparative Effectiveness of Less Commonly Used Systemic Monotherapies and Common Combination Therapies for Moderate to Severe Psoriasis in the Clinical Setting Journal of the American Academy of Dermatology. Dec, 2014 | Pubmed ID: 25260564 Patient-reported Outcomes for Psoriasis Patients with Clear Versus Almost Clear Skin in the Clinical Setting Journal of the American Academy of Dermatology. Oct, 2014 | Pubmed ID: 24928705 Palmoplantar Psoriasis is Associated with Greater Impairment of Health-related Quality of Life Compared with Moderate to Severe Plaque Psoriasis Journal of the American Academy of Dermatology. Oct, 2014 | Pubmed ID: 24894455 Practice GAPS: Preventing and Detecting Antibodies to Anti-tumor Necrosis Factor Agents: Gaps in Practice or in Evidence? JAMA Dermatology. Feb, 2014 | Pubmed ID: 24352167 Using Hawthorne Effects to Improve Adherence in Clinical Practice: Lessons from Clinical Trials--reply JAMA Dermatology. Apr, 2013 | Pubmed ID: 23715064 Variation in Dermatologist Beliefs About the Safety and Effectiveness of Treatments for Moderate to Severe Psoriasis Journal of the American Academy of Dermatology. Feb, 2013 | Pubmed ID: 22910105 Patient-reported Reasons for the Discontinuation of Commonly Used Treatments for Moderate to Severe Psoriasis Journal of the American Academy of Dermatology. Jan, 2013 | Pubmed ID: 22846688 Rare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in Psoriasis American Journal of Human Genetics. May, 2012 | Pubmed ID: 22521419 Dermatologist Preferences for Treatments to Compare in Future Randomized Controlled Comparative Effectiveness Trials for Moderate to Severe Psoriasis Archives of Dermatology. Apr, 2012 | Pubmed ID: 22508884 Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting Archives of Dermatology. Apr, 2012 | Pubmed ID: 22508874 Ustekinumab: a Review in the Treatment of Plaque Psoriasis and Psoriatic Arthritis Journal of Drugs in Dermatology : JDD. Feb, 2012 | Pubmed ID: 22270196 Dermatologist Preferences for First-line Therapy of Moderate to Severe Psoriasis in Healthy Adult Patients Journal of the American Academy of Dermatology. Mar, 2012 | Pubmed ID: 21856040 Obesity in Early Adulthood As a Risk Factor for Psoriatic Arthritis Archives of Dermatology. Jul, 2010 | Pubmed ID: 20644032 Multiple Loci Within the Major Histocompatibility Complex Confer Risk of Psoriasis PLoS Genetics. Aug, 2009 | Pubmed ID: 19680446 Association Between IL13 Polymorphisms and Psoriatic Arthritis is Modified by Smoking The Journal of Investigative Dermatology. Dec, 2009 | Pubmed ID: 19554022 Measuring Psoriasis Severity at Home Courtney Carroll1, Jónas Aðalsteinsson1, Megan Prouty1, Kristina Callis Duffin1, Gerald G. Krueger1, Jessica A. Walsh1,2, Bing-Jian Feng1 1University of Utah School of Medicine, 2Salt Lake City Veterans Affairs Health JoVE 66065 Medicina
Measuring Psoriasis Severity at Home Courtney Carroll1, Jónas Aðalsteinsson1, Megan Prouty1, Kristina Callis Duffin1, Gerald G. Krueger1, Jessica A. Walsh1,2, Bing-Jian Feng1 1University of Utah School of Medicine, 2Salt Lake City Veterans Affairs Health JoVE 66065 Medicina